Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/21165
Title: The effects of a fluoroquinolone on the growth and development of infants
Authors: Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Cerrahisi Anabilim Dalı.
Gürpınar, Arif Nuri
Balkan, Emin
Kılıç, Nizamettin
Kiriştioğlu, İrfan
Doǧruyol, Hasan
AAI-3656-2021
Keywords: Research & experimental medicine
Pharmacology & pharmacy
Ciprofloxacin
Fluoroquinolones
Guinolones
Antibacterial drugs
Sepsis
Neonates
Growth
Development
Issue Date: 1997
Publisher: Cambridge Med Publ
Citation: Gürpınar, A. N. vd. (1997). "The effects of a fluoroquinolone on the growth and development of infants". Journal of International Medical Research, 25(5), 302-306.
Abstract: Growth and development were monitored for up to 42 months in nine neonates to whom ciprofloxacin, a fluoroquinolone, was given in the neonatal period at a dosage of 20 mg/kg/day. Ciprofloxacin was used only as a 'life-saving' therapy in cases of sepsis produced by bacterial agents resistant to other antibiotics. Two other groups of nine neonates, matched by birth weight and gestational age, were studied as controls: one group with sepsis, which was effectively treated with cefotaxime and a group of healthy neonates. No statistically significant differences in growth and development between the groups were found during follow-up for 42 months. No osteoarticular problems or joint deformities were observed in the ciprofloxacin group. Ciprofloxacin appears to provide a therapeutic option as a 'life-saving' therapy for newborns with sepsis produced by multiply resistant organisms.
URI: http://hdl.handle.net/11452/21165
ISSN: 0300-0605
Appears in Collections:Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.